“Discovery of Voxilaprevir, a Pangenotypic HCV Protease Inhibitor with Improved Coverage of Resistance Associated Variants”
Dr. James Taylor
Senior Director
Medicinal Chemistry
Gilead Sciences
Location:
163 The Green
219 Brown Lab
Newark, DE 19716
Hosting Organization:
Chemistry-Biology Interface
Date:
October 25, 2017
Time:
12:00-1:00